Novo Nordisk A/S ADR buy BMO Capital Markets
Start price
12.04.24
/
50%
€119.50
Target price
12.04.25
€153.17
Performance (%)
8.37%
Price
16.07.24
€129.50
Summary
This prediction is currently active. The BUY prediction by BMO_Capital_Markets shows slight gains of 8.37%. This prediction currently runs until 12.04.25. The prediction end date can be changed by BMO_Capital_Markets at any time. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Novo Nordisk A/S ADR | -0.385% | -0.385% |
iShares Core DAX® | 1.776% | 3.175% |
iShares Nasdaq 100 | -1.037% | 1.869% |
iShares Nikkei 225® | -0.335% | 3.857% |
iShares S&P 500 | 0.854% | 2.567% |
Comments by BMO_Capital_Markets for this prediction
In the thread Novo Nordisk A/S ADR diskutieren
Novo Nordisk A/S (NYSE: NVO) is now covered by analysts at BMO Capital Markets. They set an "outperform" rating and a $163.00 price target on the stock.
Ratings data for NVO provided by MarketBeat
Stopped prediction by BMO_Capital_Markets for Novo Nordisk A/S ADR
Novo Nordisk A/S ADR
Start price
Target price
Perf. (%)
€137.00
25.06.24
25.06.24
€152.14
25.06.25
25.06.25
-5.47%
16.07.24
16.07.24